AbbVie, Cugene ink pact for CUG252 for treatment of autoimmune, inflammatory diseases Ruchika Sharma17 May 2022 4:30 AM GMTUnder the terms of the agreement, Cugene will receive an upfront payment of $48.5 million, and will also be eligible to receive development and...
Sandoz launches generic equivalent of AbbVie eyedrop Combigan in US Ruchika Sharma17 April 2022 4:45 AM GMT"Fixed combinations of medicines to treat ocular hypertension can offer patients enhanced convenience, improved adherence, reduced exposure to...
Unichem Labs gets USFDA nod for Divalproex Sodium ER Tablets Ruchika Sharma28 Feb 2022 11:18 AM GMTMumbai: Drugmaker, Unichem Laboratories Limited, today announced that the company has received approval from the United States Food and Drug...
Alembic Pharma Clarithromycin tablets get USFDA okay Ruchika Sharma1 Feb 2022 10:18 AM GMTVadodara: Drug maker, Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...
AbbVie awarded with Great Place to Work Certification Ruchika Sharma26 Dec 2021 5:00 AM GMTNew Delhi: AbbVie in India has recently been awarded a Great Place to Work Certification, recognizing AbbVie's culture of driving breakthroughs by...
USFDA adds strict safety warnings on Pfizer, AbbVie, Lilly arthritis drugs Ruchika Sharma4 Dec 2021 9:42 AM GMTNew Delhi: The U.S. health regulator has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of...
AbbVie gets Europen Commission nod for SKYRIZI to treat adults with Active Psoriatic Arthritis Ruchika Sharma18 Nov 2021 4:30 AM GMTNorth Chicago, III: AbbVie has recently announced that the European Commission (EC) has approved SKYRIZI (risankizumab, 150 mg, subcutaneous injection...
Cariprazine effective adjunctive treatment for major depressive disorder, find phase 3 trials Hina Zahid4 Nov 2021 3:30 AM GMTNORTH CHICAGO, Ill. - Cariprazine has been found effective as an adjunctive treatment for patients with major depressive disorder, according to...
Intas secures CDSCO panel nod to study arthritis drug Adalimumab Medical Dialogues Team24 Sep 2021 11:38 AM GMTNew Delhi: In a significant development, drug firm Intas has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Natco Pharma loses patent litigation case over anti-cancer drug Ibrutinib in US Medical Dialogues Team25 Aug 2021 12:42 PM GMTNew Delhi: In a major setback, Natco Pharma has lost a legal battle with Pharmacyclics, a subsidiary of AbbVie over patent of anti-cancer drug...
Pharma firms slapped USD 360 million fine after steroid price hikes over 10000 percent Ruchika Sharma16 July 2021 6:00 AM GMTCMA has fined Actavis UK, Auden Mckenzie, Allergan, Accord Healthcare, Intas, Waymade Plc, Amdipharm, Advanz Pharma and some entities of...
Lupin unveils bipolar disorder drug Divalproex Sodium ER Tablets in US Ruchika Sharma23 Sep 2020 6:45 AM GMTMumbai, Baltimore: Pharma major Lupin Limited has recently announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500...
